Overview
Dr. Risa Wolf is an Associate Professor of Pediatrics in the Division of Pediatric Endocrinology at the Johns Hopkins University School of Medicine. Her clinical practice focuses on pediatric diabetes care and other endocrine issues. Dr. Wolf received her undergraduate degree from the University of Pennsylvania, after which she attended the Mount Sinai School of Medicine where she graduated with Distinction in Research, and was inducted into the Alpha Omega Alpha Honor Medical Society. She completed her pediatric residency at the Children's Hospital of Philadelphia, followed by a fellowship in pediatric endocrinology at the Johns Hopkins Hospital. During her fellowship, Dr. Wolf was awarded prestigious grants from both the Pediatric Endocrine Society and the Endocrine Society to support her research in obesity and metabolism. Dr. Wolf also spent two years working at Broward Health in Florida, where she developed a Comprehensive Pediatric Diabetes Center. She is the Founder and Medical Director of Camp Charm City diabetes camp in Baltimore, MD. Dr. Wolf's research focus is on clinical care innovations to improve outcomes in pediatric diabetes. She is the Principal Investigator of a study implementing point-of-care diabetes retinopathy screening into pediatric diabetes care, a Co-Investigator for Trialnet, and the Principal Investigator for the Pediatric Diabetes Consortium site at Johns Hopkins. She also studies a novel family of proteins, called CTRPs, to determine their impact on glucose and lipid metabolism in the context of obesity and diabetes. Dr. Wolf is affiliated with the American Academy of Pediatrics, the Pediatric Endocrine Society, the Endocrine Society, and the American Diabetes Association. CV https://www.hopkinsmedicine.org/johns-hopkins-childrens-center/_documents/_cvs/wolf_risa_m_cv.pdf.
Her clinical expertise encompasses Type 1 Diabetes (T1D) and Pediatric Growth Hormone Deficiency.
Dr. Wolf is board certified in American Board Of Pediatrics.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
Building 1, Baltimore, MD 21287
Additional Areas of Focus
Dr. Wolf has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Telehealth Video Visit
Andrew Dauber, MD, MMSc, is the chief of endocrinology at Children’s National Hospital. As a pediatric endocrinologist, Dr. Dauber works in all areas of pediatric endocrinology, but specializes in studying and treating growth disorders. Dr. Dauber has published more than 65 studies and regularly speaks at international pediatric endocrinology conferences, discussing a variety of topics, including clinical clues to identify rare genetic growth conditions, genetic factors that influence height and the timing of puberty, as well as novel genetic disorders that he has helped identify. He is the recipient of the 2020 Richard E. Weitzman Outstanding Early Career Investigator Award from the Endocrine Society for successfully applying innovative genetic technologies to pediatric endocrinology. With a medical degree and a Master’s of Medical Sciences in Clinical Investigation from Harvard Medical School, Dr. Dauber finds it natural to merge academic research with its clinical counterparts to accelerate cutting-edge treatment and multidisciplinary care. He is currently working with pediatric health centers to integrate genomics into patient registries and electronic health records, harnessing large data sets, including whole-exome sequences, to help clinicians identify and treat high-risk patients. Over the next few years, Dr. Dauber will create an endocrinology research program at Children’s National, transforming the type of care that children with endocrine disorders receive. This will make it easier for parents to find comprehensive resources for rare conditions, thyroid problems, growth disorders, early or delayed puberty, as well as type 1 and type 2 diabetes. Dr. Dauber also has experience with guiding joint infrastructures and engines of innovation. Previously, he served as the program director and director of translational research at the interdisciplinary Cincinnati Center for Growth Disorders at Cincinnati Children’s Hospital Medical Center. Additionally, he was the director of their Genomics First for Undiagnosed Diseases Program and guided medical residents and fellows as an associate professor of pediatrics at the University of Cincinnati. He held similar roles as the assistant medical director for the clinical research unit at Boston Children’s Hospital and as an assistant professor in pediatrics at Harvard Medical School. Dr. Dauber holds board certifications in pediatrics and pediatric endocrinology from the American Board of Pediatrics. He is an active member of and has received several awards and honors from the Endocrine Society, Pediatric Endocrine Society, European Society of Pediatric Endocrinology and the Society for Pediatric Research. Dr. Dauber is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Short Stature (Growth Disorders), Hypochondroplasia, Precocious Puberty, and Growth Hormone Deficiency (GHD). Dr. Dauber is board certified in Endocrinology Diabetes And Metabolism: American Board Of Pediatrics, 2011 and Pediatrics: American Board Of Pediatrics, 2007.
Office
Rachel Gafni is a Pediatric Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Gafni is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Autosomal Dominant Hypocalcemia, Osteomalacia, Osteitis Fibrosa, Malnutrition, and Hormone Replacement Therapy (HRT).
Office
Deborah Merke is a Pediatric Endocrinologist practicing medicine in Bethesda, Maryland. Dr. Merke is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Ovarian Overproduction of Androgens, Addison's Disease, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Risa M. Wolf
How do I make an appointment with Dr. Risa M. Wolf?
You can book an appointment with Dr. Risa M. Wolf by calling their office at 443-997-5437. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Risa M. Wolf a top-rated expert for Type 1 Diabetes (T1D)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Risa M. Wolf is classified as an Experienced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Risa M. Wolf specialize in?
While Dr. Risa M. Wolf is a Pediatric Endocrinology, they have specific expertise in Type 1 Diabetes (T1D), Pediatric Growth Hormone Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.
Does Dr. Risa M. Wolf accept my insurance?
Dr. Risa M. Wolf accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 443-997-5437 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers